Navigation Links
TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
Date:5/27/2008

SAN MARINO, Calif., May 27 /PRNewswire/ -- Epeius Biotechnologies (http://www.epeiusbiotech.com) announced today that the results of a Phase I Feasibility Study of sequential targeted gene delivery -- using Rexin-G followed by Reximmune-C -- for cancer vaccination will be presented at the ASCO meetings in Chicago on June 1, 2008 (J Clin Oncol 26:3077, 2008). Rexin-G and Reximmune-C are pathotropic (disease-seeking) nanoparticles bearing a cytocidal cyclin G1 gene and a granulocyte-macrophage colony stimulating factor (GM-CSF) gene, respectively. When injected intravenously, these targeted vectors seek out and accumulate in cancerous lesions, thus increasing the effective local concentrations of the therapeutic nanoparticles within the tumors.

The working hypothesis behind this two-stage approach to cancer management predicts that strategic and individualized vaccination of a patient against his/her own cancer can be achieved by combining (1) the targeted vector bearing a potent cytocidal construct, Rexin-G, with (2) a targeted vector bearing an immune activating gene, Reximmune-C. Rexin-G is given first to kill the cancer cells and thus expose neoantigens within the tumors, followed by Reximmune-C to recruit the body's immune cells into the same tumor compartments, thereby prompting recognition of the tumor neoantigens in situ and inducing long-lasting anti-tumor immunity.

The purpose of the Phase I study was to evaluate the overall safety/toxicity and therapeutic potential of this sequential regimen, in an effort to achieve a personalized cancer vaccination in vivo. Seven patients with chemo-resistant cancer, including carcinoma of breast, colon and pancreas, non-small cell lung cancer and leiomyosarcoma, received Rexin-G i.v. at a dose of 4 x 10e10 cfu per day for 2 to 6 weeks (Cumulative Dose: 4.0 x 10e11 to 1.2 x 10e12 cfu) followed by Reximmune-C i.v. at 2.5 x 10e9 cfu for 5 days or 5
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
2. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
3. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
4. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
5. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
6. ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia
7. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
8. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
9. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
10. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
11. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., LINCOLNSHIRE,Ill.,Nov.23/PRNewswire/--Sarno...althcareproductsintheemergencymedicalservices(EMS)...ntedfourexecutivestoitsseniormanagementteam.Thenew...sales;DonnaHill,executivevicepresidentandgeneralco...;andGregRobitaille,executivevicepresidentofcorpora...
(Date:11/23/2009)..., SOUTHSANFRANCISCO,Calif.,Nov.23/PRNewswire-...cedthatDr.TedW.LoveandDr.DavidC.U,Prichardhaveagre...ionoftheproposedmergerbetweenAnesivaandArcionThera...ervotescheduledtotakeplaceatthepreviouslyannounced...ecember3,2009at9:00a.m.PSTat400OysterPoint,Suite10...
(Date:11/23/2009)..., ALISOVIEJO,Calif.,Nov.23/PRNewswire-FirstCa...maceuticals International(NYSE: VRX ),todayannounc...eandclidiniumbromide,anauthorizedgeneric(AG)versio...andexpectstobeasignificantplayerintheLibrax®g...meanimportantdivisionofourU.S.businesswithitssucce...
Breaking Medicine Technology:Sarnova Expands Senior Management Team 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 53085 1Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 53085 2Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 53085 3Kaiser Permanente Honored for Efforts to Combat Obesity With 2009 Pioneering Innovation Award at Weight of the Nation Conference 53085 4Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 1Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 2Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 3Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 4Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 5Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 6Sharing Miracles Television Program to Feature Four Time World Series Champ Darryl Strawberry 53080 7Smith 26 Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA 53076 1Smith 26 Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA 53076 2Smith 26 Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA 53076 3Smith 26 Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA 53076 4
...ciences today announced,the enrollment of the firs... Phase IIa clinical study, named REVERSAL-PCI, of ...nrolled at Black Hills Cardiology,in Rapid City, S...ective,Percutaneous Coronary Intervention (PCI) to...therapy during the performance of coronary balloon...
...ries, Inc.,(NYSE: FRX ) today announced the resul...d clinical trial, published in the November 2007 i...h demonstrated that nebivolol,significantly reduce...ed as,monotherapy among African-American patients ... that nebivolol was well tolerated in comparison t...
Other Medicine Technology:Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System 2Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System 3UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension 2UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension 3
(Date:11/23/2009)...GTON, Va. The Infectious Diseases Society of Amer...ma administration and the European Union to furthe... of 10 new antibiotics within the next 10 years, k... Organization (WHO) has identified antimicrobial r...human health. , A new European Union report conf...
(Date:11/23/2009)... iCRco is proud to announce its par... and received the highest grade possible amongst a...urer to be rated “A” in sales, service...r satisfaction in software functionality. iCRco is...grade by the most prestigious research firm in med...
(Date:11/23/2009)...EXANDRIA,Va.,Nov.23/PRNewswire/--JustintimefortheT...shomechefswithtipsandrecipesforcookingupadelicious...entnewsandhealthinformation, turkeyfrying.net ...dturkeyaswellaspartyideasfortakingtheturkeybeyondT...enticallySouthernwayofdeep-fryingwith100%peanutoil...
(Date:11/23/2009)...s findings support link between mental and physica...News) -- Being depressed might take as many years ...s. , However, a combination of depression and a...t depression. , Researchers came to their concl...of more than 60,000 people. During the four years ...
(Date:11/23/2009)...o store fat on their waist in middle age are more ... get older, reveals a new study from the Sahlgrens...in the scientific journal Neurology . , "Anyone...ater risk of dying prematurely due to a heart atta...urer at the Sahlgrenska Academy. "If they neverthe...
Breaking Medicine News(10 mins):Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3Health News:Depression May Up Death Risk to That of Smoking 2
...nnecessary expense in men 75 or older, researchers...-- Routine prostate specific antigen (PSA) blood t... new study suggests. , Researchers analyzed data f... and had regular PSA testing. , The Johns Hopkins-...
...e president, receives 2009 TEMPO Mentor Award , ,...ing together we can accomplish more than working a...e vice president of Aurora Health Care and presi...ents and has named her as one of two 2009 TEMPO Me...
...lcano Corporation (Nasdaq: VOLC ), a leader in t...s for the diagnosis and treatment of coronary and ...yst Day on Wednesday, February 25, at the NASDAQ M...tandard Time (11 a.m., Pacific Standard Time). , ...
... The AMD-2500 General Examination Camera has bee... an approved telemedicine device throughout Canada...MD Global Telemedicine Inc., the leading worldwide...r countrywide deployment., , ,The National Telehea...
...y 20, 2009 Although widespread Prostate-Specific-...ostate cancer mortality, is there a point of dimin...2009 issue of The Journal of Urology , researcher...sequently died of prostate cancer. The discontinua...
... outbreak linked to 575 illnesses and eight deaths...eanut processing plant in Georgia. And while it is...and sanitary, Temple public health professor Jenni...rocessing plant, but no one is really looking at t...
Other Medicine News:Health News:Many Older Men Won't Benefit from PSA Test 2Health News:Aurora Leader Awarded for Helping Others Reach Their Potential 2Health News:Volcano Corporation Announces Webcast of February 25th Analyst Day 2Health News:AMD Global Telemedicine, Inc is Pleased to Announce the Selection of its Examination Camera for the Canadian National Telehealth Videoconference Equipment RFP 2Health News:When should prostate-specific antigen testing be stopped? 2Health News:Field of germs 2
...he 5mm AEM Laparoscopic Instruments incorporate a ...ents are shielded and monitored to prevent stray e...ment caused by insulation failure or capacitive co... protective shield built into all AEM Instruments ...
...he 5mm AEM Laparoscopic Instruments incorporate a ...ents are shielded and monitored to prevent stray e...ment caused by insulation failure or capacitive co... protective shield built into all AEM Instruments ...
...he 5mm AEM Laparoscopic Instruments incorporate a ...ents are shielded and monitored to prevent stray e...ment caused by insulation failure or capacitive co... protective shield built into all AEM Instruments ...
...he 5mm AEM Laparoscopic Instruments incorporate a ...ents are shielded and monitored to prevent stray e...ment caused by insulation failure or capacitive co... protective shield built into all AEM Instruments ...
Medicine Products: